Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
Takashi ShinguAllen L HoLiang YuanXin ZhouCongxin DaiSiyuan ZhengQianghu WangYi ZhongQing ChangJames W HornerBrandon D LiebeltYu YaoBaoli HuYiwen ChenGregory N FullerRoeland G W VerhaakAmy B HeimbergerJian HuPublished in: Nature genetics (2016)
Stem cells, including cancer stem cells (CSCs), require niches to maintain stemness, yet it is unclear how CSCs maintain stemness in the suboptimal environment outside their niches during invasion. Postnatal co-deletion of Pten and Trp53 in mouse neural stem cells (NSCs) leads to the expansion of these cells in their subventricular zone (SVZ) niches but fails to maintain stemness outside the SVZ. We discovered that Qki is a major regulator of NSC stemness. Qk deletion on a Pten-/-; Trp53-/- background helps NSCs maintain their stemness outside the SVZ in Nes-CreERT2; QkL/L; PtenL/L; Trp53L/L mice, which develop glioblastoma with a penetrance of 92% and a median survival time of 105 d. Mechanistically, Qk deletion decreases endolysosome-mediated degradation and enriches receptors essential for maintaining self-renewal on the cytoplasmic membrane to cope with low ligand levels outside niches. Thus, downregulation of endolysosome levels by Qki loss helps glioma stem cells (GSCs) maintain their stemness in suboptimal environments outside their niches.
Keyphrases
- stem cells
- cancer stem cells
- epithelial mesenchymal transition
- cell therapy
- cell proliferation
- neural stem cells
- signaling pathway
- metabolic syndrome
- preterm infants
- pi k akt
- induced apoptosis
- adipose tissue
- cell cycle arrest
- skeletal muscle
- insulin resistance
- bone marrow
- mesenchymal stem cells
- transcription factor
- cell migration
- free survival